JFS WEALTH ADVISORS, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 3 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JFS WEALTH ADVISORS, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$14,929
-1.5%
9650.0%0.00%0.0%
Q2 2023$15,161
-24.5%
965
-20.8%
0.00%
-50.0%
Q1 2023$20,090
-8.1%
1,219
-13.1%
0.00%0.0%
Q4 2022$21,871
-83.9%
1,402
-86.6%
0.00%
-86.7%
Q3 2022$136,000
-6.2%
10,448
+1.4%
0.02%0.0%
Q2 2022$145,000
-6.5%
10,303
-4.8%
0.02%0.0%
Q1 2022$155,000
-6.6%
10,824
-11.2%
0.02%
-6.2%
Q4 2021$166,000
-8.3%
12,186
+10.2%
0.02%
-15.8%
Q3 2021$181,000
-2.7%
11,0550.0%0.02%
-32.1%
Q2 2021$186,000
+10.7%
11,055
+20.0%
0.03%
-17.6%
Q1 2021$168,000
+9.1%
9,210
+9.1%
0.03%
+6.2%
Q4 2020$154,000
+13.2%
8,439
+10.7%
0.03%0.0%
Q3 2020$136,000
+8.8%
7,621
+8.9%
0.03%0.0%
Q2 2020$125,000
+23.8%
6,998
+5.5%
0.03%
+6.7%
Q1 2020$101,000
-1.0%
6,635
+28.1%
0.03%
+20.0%
Q4 2019$102,000
+14.6%
5,1790.0%0.02%
+8.7%
Q3 2019$89,000
+74.5%
5,179
+78.7%
0.02%
+76.9%
Q2 2019$51,000
-13.6%
2,8980.0%0.01%
-13.3%
Q1 2019$59,000
+37.2%
2,898
+13.6%
0.02%
+25.0%
Q4 2018$43,0002,5520.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2023
NameSharesValueWeighting ↓
Adelphi Capital LLP 8,958,784$176,757,00033.75%
Ovata Capital Management Ltd 879,800$17,557,092,00013.04%
Paulson & Co. 13,244,711$261,318,0005.64%
Glenview Capital Management 30,582,721$603,397,0005.28%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 718,028$14,167,0004.85%
Velanne Asset Management Ltd 302,694$5,972,0003.52%
Blackcrane Capital, LLC 172,708$3,408,0002.72%
Melqart Asset Management (UK) Ltd 1,557,000$30,720,0002.57%
GMT CAPITAL CORP 3,345,976$66,016,0002.55%
REDWOOD CAPITAL MANAGEMENT, LLC 827,955$16,336,0002.24%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders